Efficacy of interferon in treating chronic hepatitis C in children with a history of acute leukemia

Blood

Volumn 87, Issue 10, 1996, Pages 4072-4075

  Komatsu, Haruki ^b   Fujisawa, Tomoo ^a   Inui, Ayano ^b   Miyakawa, Yoshihiro ^b   Onoue, Masahiro ^b   Sekine, Isao ^b   Hanada, Ryoji ^b   Yamamoto, Keiko ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; DOXORUBICIN; HEPATITIS C ANTIBODY; IMMUNOSUPPRESSIVE AGENT; VIRUS RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEART FAILURE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL RECORD; PRIORITY JOURNAL;

EID: 0029923643     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.10.4072.bloodjournal87104072     Document Type: Article

References (26)

1. Jacyna MR, Brooks MG, Loke RHT, Main J, Murray-Lyon IM, Thomas HC: Randomized controlled trial of interferon alpha (lymphoblastoid interferon) in chronic non-A, non-B hepatitis. Br Med J 298:80, 1989
2. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman, Murray L, Waggoner J, Goodman Z, Bank ST, Hoofnagle JH: Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo controlled trial. N Engl J Med 321:1506, 1989
3. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo PR, Carey W, Jacobson IM, Payne J, Dienstag JL, VanThiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, Hepatitis International Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alpha. N Engl J Med 321:1501, 1989
4. Saez-Royuela F, Porres JC, Moreno A, Castillo I, Martines G, Galiana F: High doses of recombinant alpha or gamma interferon for chronic hepatitis C. A randomized, controlled trial. Hepatology 13:327, 1991
5. Ruiz-Moreno M, Rua MJ, Molina J, Moraleda G, Moreno A, Garcia-Aguado J, Carreno V: Prospective randomized controlled trial of interferon-α in children with chronic hepatitis B. Hepatology 13:1035, 1991
6. Sokal EM, Wirth S, Goyen P, Depreterre A, Cornu C: Interferon alpha-2b therapy in children with chronic hepatitis B. Gut 34:s87, 1993 (suppl)
7. Ruiz-Moreno M, Rau MJ, Castillo I, Garcia-Novo, Santos M, Navas S, Carreno V: Treatment of children with chronic hepatitis C with recombinant interferon-α. A pilot study. Hepatology 16:882, 1992
8. Fujisawa T, Inui A, Ohkawa T, Komatsu H, Miyakawa Y, Onoue M: Response to interferon therapy in children with chronic hepatitis C. J Pediatr 127:660, 1995
9. Okamoto H, Okada S, Sugiyama, Yotsumoto S, Tanaka T, Yoshizawa H, Tsuda F, Miyazawa Y, Mayumi M: The 5′-terminal sequence of the hepatitis C genome. Jpn J Exp Med 60:16, 1990
10. Inui A, Fujisawa T, Komatsu H: Rapid detection of hepatitis C virus by direct reverse transcription-polymerase chain reaction. Int Hepatol Commun 3:126, 1995
11. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers. Application to clinical survey and tracing infectious sources. J Gen Virol 73:673, 1992
12. Ishiyama N, Katayama K, Ishimi N: Quantitative detection of hepatitis C virus RNA by multicyclic RT-PCR. Int Hepatol Commun 1:72, 1993
13. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Uehlinger E: A classification of chronic hepatitis. Lancet 2:626, 1968
14. Knodell RG: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 5:431, 1981
15. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Coppere H, Cales P, Couzigou P, Benhamou JP: Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France. Hepatology 13:393, 1991
16. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T: Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 104:877, 1993
17. Camps J, Garcia-Granero M, Riezu-Boj JI, Larrea E, Alava ED, Civeria MP, Castilla A, Prieto J: Prediction of sustained remission of hepatitis C after a 12-month course of alfa interferon. J Hepatol 21:4, 1994
18. Serfaty L, Giral P, Loris A, Andreani T, Legendre C, Poupon R: Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol 21:12, 1994
19. Hagiwara H, Hayashi N, Mita E, Ueda K, Takehara T, Kasahara A, Fusamoto H, Kamada T: Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. Hepatology 15:37, 1992
20. Fujisawa T, Ohkawa T, Inui A, Yokota S: Effect of interferon therapy on serum hepatitis C virus RNA levels in children with chronic hepatitis C. Int Hepatol Commun 2:316, 1994
21. Inui A, Fujisawa T, Miyagawa Y, Sekine I, Hanada R, Yamamoto K, Shiihara H, Inui M: Histologic activity of the liver in children with transfusion associated chronic hepatitis C. J Hepatol 21:748, 1994
22. Arico M, Maggiore G, Silini E, Bono F, Vigano C, Cerino A, Mondelli M: Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 84:2419, 1994
23. Kanai K, Kako M, Okamoto H: HCV genotypes in chronic hepatitis C and response to interferon. Lancet 339:1543, 1992
24. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, Fusamoto H, Komada T: Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci 39:977, 1994
25. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 434:808, 1991
26. Ali MK, Ewer MS, Gibbs HR, Swafford J, Graff KL: Late doxorubicin-associated cardiotoxicity in children. Cancer 74:182, 1994